Pages that link to "Q37026062"

The following pages link to Understanding mechanisms of toxicity: insights from drug discovery research (Q37026062):

Displaying 29 items.

• Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms (Q28530398) (← links)
• Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes (Q28728799) (← links)
• Novel Uses of In Vitro Data to Develop Quantitative Biological Activity Relationship Models for in Vivo Carcinogenicity Prediction (Q31119555) (← links)
• Use of in vitro HTS-derived concentration-response data as biological descriptors improves the accuracy of QSAR models of in vivo toxicity (Q33729965) (← links)
• A high-throughput respirometric assay for mitochondrial biogenesis and toxicity (Q33976815) (← links)
• Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. (Q34181630) (← links)
• Towards a strategic approaches in alternative tests for pesticide safety (Q34389851) (← links)
• Adaptation of high-throughput screening in drug discovery-toxicological screening tests. (Q35719340) (← links)
• Organotypic liver culture models: meeting current challenges in toxicity testing (Q36178225) (← links)
• Survey of public domain software for docking simulations and virtual screening. (Q36477022) (← links)
• Cytotoxicity and biocompatibility of Zirconia (Y-TZP) posts with various dental cements. (Q37159411) (← links)
• Toxicity testing in the 21st century: bringing the vision to life (Q37346896) (← links)
• Cellular stress response pathway system as a sentinel ensemble in toxicological screening (Q37536673) (← links)
• Predictive toxicology approaches for small molecule oncology drugs (Q37675456) (← links)
• The future of toxicity testing (Q37767386) (← links)
• Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century (Q37839767) (← links)
• In Vitro Safety Pharmacology Profiling: What Else Beyond Herg? (Q37855844) (← links)
• Systems biology of cyanobacterial secondary metabolite production and its role in drug discovery. (Q38088802) (← links)
• Drug safety testing paradigm, current progress and future challenges: an overview (Q38207946) (← links)
• The use of high-throughput screening in identifying chemotherapeutic agents for gastric cancer (Q38297145) (← links)
• In vitro testing of basal cytotoxicity: Establishment of an adverse outcome pathway from chemical insult to cell death. (Q39035038) (← links)
• Real-time bioluminescent tracking of cellular population dynamics (Q39069380) (← links)
• Establishing a high-throughput and automated cancer cell proliferation panel for oncology lead optimization (Q39144212) (← links)
• The Use of Real-Time Cell Analyzer Technology in Drug Discovery: Defining Optimal Cell Culture Conditions and Assay Reproducibility with Different Adherent Cellular Models (Q39553310) (← links)
• Comparison of MTT assay, flow cytometry, and RT‐PCR in the evaluation of cytotoxicity of five prosthodontic materials (Q39650186) (← links)
• Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals (Q39826629) (← links)
• Computational toxicology: realizing the promise of the toxicity testing in the 21st century (Q42540572) (← links)
• Systems biology and mode of action based risk assessment (Q47348202) (← links)
• Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk (Q51686463) (← links)